Search Results 571-580 of 16041 for pharmacogenetics

  1. Mayo Clinic Radio: Individualizing Medicine 2018 conference

    Individualized medicine, also known as personalized medicine or precision medicine, means tailoring diagnosis and treatment to each patient to optimize care ...

  2. Evolocumab (subcutaneous route) - Mayo Clinic

    Description. Evolocumab injection is used together with a proper diet, alone or together with other medicines (eg, ezetimibe, statins), to treat patients ...

  3. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

    Paclitaxel and carboplatin are chemotherapy drugs used as part of the usual treatment approach for this type of cancer. This study aims to assess if adding ...

  4. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.

  5. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrent C. Diff - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness, safety and tolerability of Oral Full-Spectrum MicrobiotaTM (CP101) in subjects with recurrence of ...

  6. For Patients - Mayo Clinic Research

    Explore resources and patient stories related to epilepsy and brain tumors from Mayo Clinic's Device Development and Experimental Therapeutics Lab.

  7. Division of Experimental Pathology and Laboratory Medicine

    Mayo Clinic's Division of Experimental Pathology and Laboratory Medicine uses molecular and cellular biology and epidemiological tools to study the ...

  8. Publications - Pavel N. Pichurin, M.D. - Mayo Clinic

    Impact of integrated translational research on clinical exome sequencing. Genet Med. 2021 Mar; 23(3):498-507. Epub 2020 Nov 04. View PubMed; Pinto E Vairo F, ...

  9. Guiding Evidence Based Therapy Using Biomarker Intensified Treatment - Mayo Clinic

    Inclusion Criteria: Age 18 years or older; Most recent LVEF to be ≤ 40% by any method within 12 months of randomization. High risk heart failure as defined ...

  10. A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Pegcetacoplan in Patients With TA-TMA After Hematopoietic Stem Cell Transplantation (HSCT) - Mayo Clinic

    A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Pegcetacoplan in Patients With TA-TMA After Hematopoietic Stem Cell Transplantation ( ...